I¹ imidazoline receptors: clinical relevance in hypertensive patientsMANCIA, Giuseppe.American journal of hypertension. 2000, Vol 13, Num 6, issn 0895-7061, 45 p., 2Conference Proceedings

I₁-Imidazoline-receptor agonists : a new concept in hypertension. Satellite symposiumPAPP, J. Gy; OLLIVIER, J.-P.Journal of cardiovascular pharmacology. 1994, Vol 24, issn 0160-2446, SUP1Conference Proceedings

I₁-imidazoline-receptor agonists in the treatment of hypertension : an appraisal of clinical experienceOLLIVIER, J.-P; CHRISTEN, M. O.Journal of cardiovascular pharmacology. 1994, Vol 24, pp S39-S48, issn 0160-2446, SUP1Conference Paper

A novel mechanism of action for hypertension control : moxonidine as a selective I₁-imidazoline agonistERNSBERGER, P; HAXHIU, M. A; GRAFF, L. M et al.Cardiovascular drugs and therapy. 1994, Vol 8, pp 27-41, issn 0920-3206, SUP1Article

Renal I₁-imidazoline receptor-selective compounds mediate natriuresis in the ratSMYTH, D. D; PENNER, S. B.Journal of cardiovascular pharmacology. 1995, Vol 26, pp S63-S67, issn 0160-2446, SUP2Conference Paper

Identification and characterization of I₁ imidazoline receptors : Their role in blood pressure regulationBOUSQUET, P.American journal of hypertension. 2000, Vol 13, Num 6, pp 84S-88S, issn 0895-7061, 2Conference Paper

Safety and tolerability of moxonidine in the treatment of hypertensionSCHACHTER, M; LUSZICK, J; JÄGER, B et al.Drug safety. 1998, Vol 19, Num 3, pp 191-203, issn 0114-5916Article

Investigation of I₁-imidazoline receptors using microphysiometry and molecular modellingMUSGRAVE, I. F; HUGHES, R. A.Journal of the autonomic nervous system. 1998, Vol 72, Num 2-3, pp 137-146, issn 0165-1838Conference Paper

The I₁-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medullaERNSBERGER, P; HAXHIU, M. A.American journal of physiology. Regulatory, integrative and comparative physiology. 1997, Vol 42, Num 5, pp R1572-R1579, issn 0363-6119Article

Mechanisms of cardiac cell damage due to catecholamines : significance of drugs regulating central sympathetic outflowRUPP, H; DHALLA, K. S; DHALLA, N. S et al.Journal of cardiovascular pharmacology. 1994, Vol 24, pp S16-S24, issn 0160-2446, SUP1Conference Paper

New imidazoline/α₂-adrenoceptors affecting compounds—4(5)—(2—aminoethyl)imidazoline (dihydrohistamine) derivatives. Synthesis and receptor affinity studiesTREDER, Adam P; ANDRUSZKIEWICZ, Ryszard; ZGODA, Włodzimierz et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 1, pp 156-167, issn 0968-0896, 12 p.Article

The I₁-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stressWENZEL, Rend R; MITCHELL, Anna; SIFFERT, Winfried et al.British journal of clinical pharmacology. 2004, Vol 57, Num 5, pp 545-551, issn 0306-5251, 7 p.Article

Arachidonic acid release from PC12 pheochromocytoma cells is regulated by I₁-imidazoline receptorsEMSBERGER, P.Journal of the autonomic nervous system. 1998, Vol 72, Num 2-3, pp 147-154, issn 0165-1838Conference Paper

Historic aspects in the identification of the I₁ receptor and the pharmacology of imidazolinesDOMINIAK, P.Cardiovascular drugs and therapy. 1994, Vol 8, pp 21-26, issn 0920-3206, SUP1Article

Clinical experience with moxonidinePRICHARD, B. N. C.Cardiovascular drugs and therapy. 1994, Vol 8, pp 49-58, issn 0920-3206, SUP1Article

Twenty-four-hour blood pressure profiles in patients with mild-to-moderate hypertension : moxonidine versus captoprilKRAFT, K; VETTER, H.Journal of cardiovascular pharmacology. 1994, Vol 24, pp S29-S33, issn 0160-2446, SUP1Conference Paper

Pharmacology and function of imidazole 4-acetic acid in brainTUNNICLIFF, G.General pharmacology. 1998, Vol 31, Num 4, pp 503-509, issn 0306-3623Article

Naphazoline-induced suppression of aqueous humor pressure and flow : Involvement of central and peripheral α₂/I₁ receptorsOGIDIGBEN, Miller J; CHU, Teh-Ching; POTTER, David E et al.Experimental eye research. 2001, Vol 72, Num 3, pp 331-339, issn 0014-4835Article

Pharma-clinics le médicament du mois: La moxonidine (Moxon®) = Moxonidine (Moxon®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 2000, Vol 55, Num 1, pp 61-63, issn 0370-629XArticle

Pharmacological characterization of I₁ and I₂ imidazoline receptors in human striatumFLAMEZ, A; DE BACKER, J.-P; CZERWIEC, E et al.Neurochemistry international. 1997, Vol 30, Num 1, pp 25-29, issn 0197-0186Article

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertensionPRICHARD, Brian N. C; JÄGER, Bodo A; LUSZICK, Joachim H et al.Blood pressure. 2002, Vol 11, Num 3, pp 166-172, issn 0803-7051Article

Membrane localization and guanine nucleotide sensitivity of medullary I₁-imidazoline binding sitesERNSBERGER, P; SHEN, I.-H.Neurochemistry international. 1997, Vol 30, Num 1, pp 17-23, issn 0197-0186Article

Selectivity of rilmenidine for I₁-imidazoline-binding sites in rabbit proximal tubule cellsGARGALIDIS-MOUDANOS, C; PARINI, A.Journal of cardiovascular pharmacology. 1995, Vol 26, pp S59-S62, issn 0160-2446, SUP2Conference Paper

Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive ratsPING LI; PENNER, S. B; SMYTH, D. D et al.British journal of pharmacology. 1994, Vol 112, Num 1, pp 200-206, issn 0007-1188Article

Selective antihypertensive action of moxonidine is mediated mainly by I₁-imidazoline receptors in the rostral ventrolateral medullaHAXHIU, M. A; DRESHAJ, I; SCHÄFER, S. G et al.Journal of cardiovascular pharmacology. 1994, Vol 24, pp S1-S8, issn 0160-2446, SUP1Conference Paper